Cargando…

1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections

BACKGROUND: The aim of this study was to determine the prevalence and the clinical significance of multidrug-resistant microorganisms (MDROs) isolated from patients with intra-abdominal infections. METHODS: This cohort study was conducted at a 1,051-bed university-affiliated hospital in the Republic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyung Yoon, Young, Yeon Kim, Jeong, Lee, Hojin, Bean Kim, Sun, Hun Kim, Jong, Wook Sohn, Jang, Ja Kim, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809152/
http://dx.doi.org/10.1093/ofid/ofz360.1363
_version_ 1783461914836205568
author Kyung Yoon, Young
Yeon Kim, Jeong
Lee, Hojin
Bean Kim, Sun
Hun Kim, Jong
Wook Sohn, Jang
Ja Kim, Min
author_facet Kyung Yoon, Young
Yeon Kim, Jeong
Lee, Hojin
Bean Kim, Sun
Hun Kim, Jong
Wook Sohn, Jang
Ja Kim, Min
author_sort Kyung Yoon, Young
collection PubMed
description BACKGROUND: The aim of this study was to determine the prevalence and the clinical significance of multidrug-resistant microorganisms (MDROs) isolated from patients with intra-abdominal infections. METHODS: This cohort study was conducted at a 1,051-bed university-affiliated hospital in the Republic of Korea, between 2016 and 2018. The subjects included patients with intra-abdominal infections who had identified causative organisms. Patients with spontaneous bacterial peritonitis were not included in our study. Identification and antimicrobial susceptibility testing were done by standard criteria as defined by the Clinical and Laboratory Standards Institute. RESULTS: During the study period, a total of 627 non-duplicated clinical isolates were collected from 430 patients. Among these patients, 196 patients (45.6%) were suffered from generalized peritonitis while 234 (54.4%) affected by localized peritonitis or abscesses. In total, 152 (35.3%) were affected by healthcare-associated infections. The overall mortality and the 28-day mortality rate were 6.3% and 5.8%, respectively. Distribution of causative microorganisms was as follows: aerobic gram-positive (40.5%), aerobic gram-negative (56.1%), anaerobic (1.9%), and fungal (1.4%) pathogens. Escherichia coli (24.2%) was isolated most frequently, followed by Enterococcus spp. (23.9%), Klebsiella spp. (16.3%), and Streptococcus spp. (11.8%). The MDROs represented 15.8% of the total of isolated micro-organisms (figure). In the multivariable logistic regression analysis, isolation of MDROs (odds ratio [OR], 3.72; 95% confidence interval [CI], 1.53–9.04), hypoalbuminemia (OR, 5.56; 95% CI, 1.25–24.75), immunosuppressant (OR, 6.29; 95% CI, 1.96–20.18), and underlying renal diseases (OR, 4.29; 95% CI, 1.66–11.11) were found as independent risk factors for 28-day mortality. CONCLUSION: In conclusion, our study indicates that MDROs are widespread in the patients with intra-abdominal infections. Furthermore, the isolation of MDROs was associated with poor clinical outcomes. For the appropriate selection of empirical antibiotics, local epidemiology of causative microorganisms and patterns of antimicrobial resistance should be continuously monitored. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809152
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68091522019-10-28 1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections Kyung Yoon, Young Yeon Kim, Jeong Lee, Hojin Bean Kim, Sun Hun Kim, Jong Wook Sohn, Jang Ja Kim, Min Open Forum Infect Dis Abstracts BACKGROUND: The aim of this study was to determine the prevalence and the clinical significance of multidrug-resistant microorganisms (MDROs) isolated from patients with intra-abdominal infections. METHODS: This cohort study was conducted at a 1,051-bed university-affiliated hospital in the Republic of Korea, between 2016 and 2018. The subjects included patients with intra-abdominal infections who had identified causative organisms. Patients with spontaneous bacterial peritonitis were not included in our study. Identification and antimicrobial susceptibility testing were done by standard criteria as defined by the Clinical and Laboratory Standards Institute. RESULTS: During the study period, a total of 627 non-duplicated clinical isolates were collected from 430 patients. Among these patients, 196 patients (45.6%) were suffered from generalized peritonitis while 234 (54.4%) affected by localized peritonitis or abscesses. In total, 152 (35.3%) were affected by healthcare-associated infections. The overall mortality and the 28-day mortality rate were 6.3% and 5.8%, respectively. Distribution of causative microorganisms was as follows: aerobic gram-positive (40.5%), aerobic gram-negative (56.1%), anaerobic (1.9%), and fungal (1.4%) pathogens. Escherichia coli (24.2%) was isolated most frequently, followed by Enterococcus spp. (23.9%), Klebsiella spp. (16.3%), and Streptococcus spp. (11.8%). The MDROs represented 15.8% of the total of isolated micro-organisms (figure). In the multivariable logistic regression analysis, isolation of MDROs (odds ratio [OR], 3.72; 95% confidence interval [CI], 1.53–9.04), hypoalbuminemia (OR, 5.56; 95% CI, 1.25–24.75), immunosuppressant (OR, 6.29; 95% CI, 1.96–20.18), and underlying renal diseases (OR, 4.29; 95% CI, 1.66–11.11) were found as independent risk factors for 28-day mortality. CONCLUSION: In conclusion, our study indicates that MDROs are widespread in the patients with intra-abdominal infections. Furthermore, the isolation of MDROs was associated with poor clinical outcomes. For the appropriate selection of empirical antibiotics, local epidemiology of causative microorganisms and patterns of antimicrobial resistance should be continuously monitored. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809152/ http://dx.doi.org/10.1093/ofid/ofz360.1363 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Kyung Yoon, Young
Yeon Kim, Jeong
Lee, Hojin
Bean Kim, Sun
Hun Kim, Jong
Wook Sohn, Jang
Ja Kim, Min
1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
title 1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
title_full 1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
title_fullStr 1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
title_full_unstemmed 1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
title_short 1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
title_sort 1499. distribution and clinical implication of isolation of multidrug-resistant microorganisms in patients with intra-abdominal infections
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809152/
http://dx.doi.org/10.1093/ofid/ofz360.1363
work_keys_str_mv AT kyungyoonyoung 1499distributionandclinicalimplicationofisolationofmultidrugresistantmicroorganismsinpatientswithintraabdominalinfections
AT yeonkimjeong 1499distributionandclinicalimplicationofisolationofmultidrugresistantmicroorganismsinpatientswithintraabdominalinfections
AT leehojin 1499distributionandclinicalimplicationofisolationofmultidrugresistantmicroorganismsinpatientswithintraabdominalinfections
AT beankimsun 1499distributionandclinicalimplicationofisolationofmultidrugresistantmicroorganismsinpatientswithintraabdominalinfections
AT hunkimjong 1499distributionandclinicalimplicationofisolationofmultidrugresistantmicroorganismsinpatientswithintraabdominalinfections
AT wooksohnjang 1499distributionandclinicalimplicationofisolationofmultidrugresistantmicroorganismsinpatientswithintraabdominalinfections
AT jakimmin 1499distributionandclinicalimplicationofisolationofmultidrugresistantmicroorganismsinpatientswithintraabdominalinfections